Levocarnitine Sf(Levocarnitine)
ANIP
Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by ANI Pharmaceuticals, Inc.
$79K
Medicare cost, 2024
$79K
Medicare cost, 2024
Medicare drug plans spent $78,675 on Levocarnitine Sf (levocarnitine) in 2024, for 1,013 prescriptions and refills filled by 150 patients. Spending fell 25% from 2023 to 2024. Ohio accounts for the most spending ($8,016, 10% of the total). It is made by ANI Pharmaceuticals, Inc. (ANIP).
Medicare cost, 2024
$79K
-24.7% from 2023
Prescriptions
1,013
$77.67 per claim
Patients
150
169 prescribers
Total spending, 2024
$79K
$524.50 per patient
Questions and answers
How much does Medicare spend on Levocarnitine Sf?
Medicare prescription drug plans paid $79K for Levocarnitine Sf in 2024, for 1,013 prescriptions and refills to 150 patients (down 24.7% from 2023). The average cost per claim was $77.67.
Which state spends the most on Levocarnitine Sf?
Ohio had the highest Medicare cost for Levocarnitine Sf in 2024: $8,016 for 130 claims, followed by Michigan ($7,204).
Who prescribes Levocarnitine Sf the most?
Ayesha Ahmad, neurology in Washington, DC, had the highest Medicare cost for Levocarnitine Sf in 2024: 12 claims costing $3,723.
Who makes Levocarnitine Sf?
Levocarnitine Sf is made by ANI Pharmaceuticals, Inc. (ANIP), listed in the Medicare spending data as Novitium/Ani Ph.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Levocarnitine Sf was $79K in 2024, after a high of $104K in 2023.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Levocarnitine Sf, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Ayesha Ahmad Washington, DC | Neurology | 12 | Under 11 | $3,723 |
| Temenuzhka G Mihaylova Ann Arbor, MI | Neurology | 20 | Under 11 | $3,362 |
| Rosalyn W Stewart Baltimore, MD | Pediatric Medicine | 12 | Under 11 | $2,377 |
| Bernard T Sy Lebanon, TN | Internal Medicine | 25 | Under 11 | $1,844 |
| Steven S Kim Rolling Meadows, IL | Internal Medicine | 53 | Under 11 | $1,771 |
| Shaya Khabyeh-Hasbani Brooklyn, NY | Internal Medicine | 44 | Under 11 | $1,725 |
| Ritu Rastogi Wilmington, DE | Internal Medicine | 52 | Under 11 | $1,681 |
| Dawn T Zapinski Whiteland, IN | Neurology | 13 | Under 11 | $1,591 |
| Francis Dimario Hartford, CT | Neurology | 11 | Under 11 | $1,562 |
| Jairon D Downs Raleigh, NC | Physical Medicine and Rehabilitation | 11 | Under 11 | $1,521 |
| Melissa A Diggin Beverly, MA | Nurse Practitioner | 11 | Under 11 | $1,392 |
| Orlando Hernandez Cincinnati, OH | Internal Medicine | 18 | Under 11 | $1,271 |
| Wade Fornander Lincoln, NE | Family Practice | 14 | Under 11 | $1,107 |
| Simon M Glynn Ann Arbor, MI | Neurology | 12 | Under 11 | $1,080 |
| Bonnie Taft Stanford, CA | Nurse Practitioner | 12 | Under 11 | $1,030 |
| Jennifer N Brinton Salt Lake City, UT | Pediatric Medicine | 39 | Under 11 | $1,022 |
| Carol N Larsen Sioux Falls, SD | Physician Assistant | 15 | Under 11 | $938 |
| Elizabeth H Koontz Charleston, SC | Nurse Practitioner | 11 | Under 11 | $820 |
| Terence A Frinks Tucker, GA | Family Practice | 20 | Under 11 | $773 |
| Afshan Hameeduddin Schaumburg, IL | Family Practice | 21 | Under 11 | $757 |
| Chloe E Hill Ann Arbor, MI | Neurology | 14 | Under 11 | $623 |
| Katherine K Katsoyannis Park Ridge, IL | Internal Medicine | 14 | Under 11 | $616 |
| Daniel Miller Columbus, OH | Internal Medicine | 14 | Under 11 | $539 |
| Naveena Nelson Cincinnati, OH | Hospice and Palliative Care | 16 | Under 11 | $526 |
| Olga Lansky Chicago, IL | Internal Medicine | 18 | Under 11 | $522 |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 149 | 624 | 126 | $88K |
| 2023 | 184 | 895 | 159 | $104K |
| 2024 | 169 | 1,013 | 150 | $79K |
Makers, 2024
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novitium/Ani Ph | 1,013 | $79K |
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through September 2026, 3,682 side-effect reports named levocarnitine, the active ingredient of Levocarnitine Sf (reports from 2004 on). 2,842 of them (77.2%) were serious, 401 named a death and 1,730 named a hospital stay. The reactions named most often were seizure, off label use and vomiting. 1,763 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
3,682
356 in 2025 (-13.2% from 2024)
Serious
77.2%
2,842 reports
Deaths named
401
10.9% of reports
Hospital stays
1,730
47.0% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Levocarnitine Sf?
3,682 reports from 2004 through September 2026 named levocarnitine, the active ingredient of Levocarnitine Sf. 2,842 of them (77.2%) were serious, 401 named a death and 1,730 named a hospital stay.
What are the most reported side effects of Levocarnitine Sf?
400 reports named seizure, the reaction named most often, followed by off label use (310) and vomiting (233). In the last 5 years the reaction named most often was off label use (234 reports). A report can name several reactions.
How many side-effect reports named Levocarnitine Sf in 2025?
356 reports were received in 2025 (-13.2% from 2024). 2026 so far: 223 reports through September 2026, and more keep arriving late.
Do side-effect reports prove that Levocarnitine Sf caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Levocarnitine Sf caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
- Other Medicare drug pages with levocarnitine: Levocarnitine, Carnitor, Carnitor Sf, Carnitor*, Levocarnitine*
- Makers on the stock market:
ANIP·ANIP drug pipeline - Drug approvals (13 approvals on file for levocarnitine) · Clinical trials · Medicare drug spending
Side-effect reports from official public data, counted per active ingredient (levocarnitine) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.